Ultrasound-guided adductor canal block using levobupivacaine versus periarticular levobupivacaine infiltration after totalknee arthroplasty: a randomized clinical trial.

CONCLUSION: ACB-L was superior to PAI-L regarding pain treatment after TKA; however, PAI-L was superior to ACB-L regarding postoperative ROM and walking ability. CLINICAL TRIAL REGISTRY: ACTRN-12618000438257. PMID: 31116270 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31116270?dopt=Abstract

Source: Sao Paulo Medical Journal - May 7, 2019 Category: General Medicine Authors: Cicekci F, Yildirim A, Önal Ö, Celik JB, Kara I Tags: Sao Paulo Med J Source Type: research